Table 5.
Treatment | Hours | |||
---|---|---|---|---|
12 h | 24 h | 48 h | 72 h | |
Control | ||||
OD | 0.15 ± 0.02 | 0.17 ± 0.01 | 0.17 ± 0.00 | 0.17 ± 0.01 |
Number (104) | 1.10 ± 0.10 | 1.13 ± 0.12 | 1.20 ± 0.17 | 1.20 ± 0.10 |
FBI | ||||
OD | 0.16 ± 0.01 | 0.17 ± 0.01 | 0.17 ± 0.02 | 0.17 ± 0.02 |
Number (104) | 1.17 ± 0.06 | 1.13 ± 0.15 | 1.17 ± 0.12 | 1.17 ± 0.15 |
TC | ||||
OD | 0.16 ± 0.01 | 0.17 ± 0.01 | 0.17 ± 0.00 | 0.17 ± 0.01 |
Number (104) | 1.13 ± 0.06 | 1.13 ± 0.06 | 1.20 ± 0.17 | 1.20 ± 0.10 |
Control: NRK-52E culture in FBS-free medium;
FIB: NRK-52E co-culture with renal fibroblasts in FBS-free medium;
TC: NRK-52E co-culture with renal telocytes in FBS-free medium.